C. Felipe

发表

Randomized crossover study to assess the inter‐ and intrasubject variability of morning mycophenolic acid concentrations from enteric‐coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipients

H. Tedesco-Silva, C. Felipe, Sung I Park, 2010, Clinical transplantation.

FTY720

C. Felipe, H. Silva, J. M. Pestana, 2002 .

Exploratory calcineurin inhibitor-free regimens in living-related kidney transplant recipients.

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Conversion from azathioprine to mycophenolate mofetil followed by calcineurin inhibitor minimization or elimination in patients with chronic allograft dysfunction.

H. Tedesco-Silva, C. Felipe, P. Pinheiro-Machado, 2006, Transplantation proceedings.

Enteric-Coated Mycophenolate Sodium Provides Higher Mycophenolic Acid Predose Levels Compared With Mycophenolate Mofetil: Implications for Therapeutic Drug Monitoring

K. Budde, P. Glander, H. Neumayer, 2007, Therapeutic drug monitoring.

Circadian and time‐dependent variability in tacrolimus pharmacokinetics

H. Tedesco-Silva, C. Felipe, Sung I Park, 2007, Fundamental & clinical pharmacology.

Cost-Effectiveness Analysis of Everolimus versus Mycophenolate in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis for Cytomegalovirus Infection: A Short-Term Pharmacoeconomic Evaluation (12 Months).

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2017, Value in health regional issues.

Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data

G. Knoll, M. Guba, R. Ducharme, 2014, BMJ : British Medical Journal.

The Emerging Role of Brazil in Clinical Trial Conduct for Transplantation

M. Abbud-Filho, C. Felipe, J. Medina-Pestana, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Is low birth weight an additional risk factor for hypertension in paediatric patients after kidney transplantation?

M. Franco, C. Felipe, J. Medina-Pestana, 2019, Journal of Developmental Origins of Health and Disease.

Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes

C. Felipe, L. A. Moura, L. Viana, 2020, PloS one.

CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy.

M. Hirata, S. Aliño, M. J. Herrero, 2020, Pharmacogenomics.

The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis

D. Segev, A. Massie, H. Tedesco-Silva, 2020, Transplantation.

Use of mTOR inhibitor as prophylaxis for cytomegalovirus disease after kidney transplantation: A natural experiment

C. Felipe, J. Medina-Pestana, L. Viana, 2019, Clinical transplantation.

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients

M. Hirata, H. Tedesco-Silva, C. Felipe, 2018, Front. Pharmacol..

Transition from Antigenemia to Quantitative Nucleic Acid Amplification Testing in Kidney Transplant Recipients Receiving Preemptive Therapy for Cytomegalovirus Infection.

H. Tedesco-Silva, C. Felipe, L. Viana, 2021 .

Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses

M. Franco, C. Felipe, J. Medina-Pestana, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Influence of immunosuppressive drugs on the CD30 molecule in kidney transplanted patients.

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2018, Human immunology.

Prospective randomized study comparing everolimus and mycophenolate sodium in de novo kidney transplant recipients from expanded criteria deceased donor

C. Felipe, J. Medina-Pestana, M. Gerbase-DeLima, 2019, Transplant international : official journal of the European Society for Organ Transplantation.

Heightened expression of HLA-DQB1 and HLA-DQB2 in pre-implantation biopsies predicts poor late kidney graft function.

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2018, Human immunology.

Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2017, American Journal of Nephrology.

Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine.

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients

M. Hirata, H. Tedesco-Silva, C. Felipe, 2016, Pharmacogenetics and genomics.

CONVERSION FROM CYCLOSPORINE TO EVEROLIMUS LEADS TO BETTER RENAL FUNCTION AND TO PROFOUND CHANGES IN EVEROLIMUS AND MYCOPHENOLATE METABOLISM

K. Budde, W. Arns, P. Glander, 2006 .

Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation.

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

An open‐label randomized trial of the safety and efficacy of sirolimus vs. azathioprine in living related renal allograft recipients receiving cyclosporine and prednisone combination

C. Felipe, Sung I Park, R. Garcia, 2004, Clinical transplantation.

Choosing the right dose of new immunossuppressive drugs for new populations: importance of pharmacokinetic studies.

C. Felipe, S. Moreira, H. Silva, 2001, Transplantation proceedings.

The effect of anti‐thymocyte globulin and everolimus on the kinetics of cytomegalovirus viral load in seropositive kidney transplant recipients without prophylaxis

C. Felipe, J. Medina-Pestana, L. Viana, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Planned Randomized Conversion From Tacrolimus to Sirolimus‐Based Immunosuppressive Regimen in De Novo Kidney Transplant Recipients

C. Felipe, J. O. Pestana, H. Silva, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2015, PloS one.

Adequacy of Initial Everolimus Dose, With and Without Calcineurin Inhibitors, in Kidney Transplant Recipients

C. Felipe, J. Medina-Pestana, D. Casarini, 2017, Therapeutic drug monitoring.

The impact of ethnic miscegenation on tacrolimus clinical pharmacokinetics and therapeutic drug monitoring

C. Felipe, R. Garcia, H. Silva, 2002, Clinical transplantation.

Prospective Randomized Trial Investigating the Influence of Pharmaceutical Care on the Intra-Individual Variability of Tacrolimus Concentrations Early After Kidney Transplant

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2016, Therapeutic drug monitoring.

Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses.

C. Felipe, J. M. Medina Pestana, T. A. Miranda, 2020, Therapeutic drug monitoring.

Influence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipients

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2017, Drug metabolism and personalized therapy.

Post-transplant soluble CD30 levels are associated with early subclinical rejection in kidney transplantation.

C. Felipe, J. Medina-Pestana, M. Gerbase-DeLima, 2015, Transplant immunology.

Time‐Dependent and Immunosuppressive Drug–Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens

H. Tedesco-Silva, C. Felipe, M. Felix, 2016, Pharmacotherapy.

Determination of Sirolimus Blood Concentration Using High‐Performance Liquid Chromatography with Ultraviolet Detection

C. Felipe, D. Casarini, G. D. di Marco, 2003, Therapeutic drug monitoring.

Pharmacokinetics and Long-Term Safety and Tolerability of Everolimus in Renal Transplant Recipients Converted From Cyclosporine

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2016, Therapeutic drug monitoring.

Reviewing 15 years of experience with sirolimus.

C. Felipe, H. Silva, J. M. Pestana, 2015 .

Cyclosporine and sirolimus pharmacokinetics and drug‐to‐drug interactions in kidney transplant recipients

C. Felipe, P. Pinheiro-Machado, R. Garcia, 2009, Fundamental & clinical pharmacology.

Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus‐based immunosuppressive regimen

M. Franco, C. Felipe, Sung I Park, 2007, Clinical transplantation.

Time‐dependent changes in cyclosporine exposure: implications for achieving target concentrations

C. Felipe, R. Garcia, H. Silva, 2003 .

A single-center open label randomized trial of the safety and efficacy of the use of sirolimus versus azathioprine in one-haplotype living related kidney transplant recipients-preliminary results.

M. Franco, J. O. Medina, C. Felipe, 2001, Transplantation proceedings.

De novo everolimus for recipients of kidney transplants from HLA identical donors.

M. Franco, H. Tedesco-Silva, C. Felipe, 2016, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

Cytomegalovirus Infections in Everolimus-Based Treatment

H. Tedesco-Silva, C. Felipe, T. Sandes-Freitas, 2013 .

Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti‐thymocyte globulin without CMV prophylaxis – a cohort single‐center study

D. Segev, A. Massie, H. Tedesco-Silva, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study.

M. Hirata, H. Tedesco-Silva, C. Felipe, 2020, Epigenomics.

Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy.

M. Franco, H. Tedesco-Silva, C. Felipe, 2013, Transplant immunology.

A Prospective Randomized Trial Aimed to Reduce the Incidence of Cytomegalovirus (CMV) Infection in Kidney Transplant Recipients.: Abstract# D2371

M. Franco, C. Felipe, J. M. Pestana, 2012 .

The influence of mTOR inhibitors on the incidence of CMV infection in high‐risk donor positive–recipient negative (D+/R−) kidney transplant recipients

H. Tedesco-Silva, C. Felipe, L. Viana, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

CIRCADIAN AND TIME-DEPENDENT VARIABILITY IN TACROLIMUS PHARMACOKINETICS

H. Tedesco-Silva, C. Felipe, P. Pinheiro-Machado, 2004, Fundamental & clinical pharmacology.

Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy

M. Hirata, H. Tedesco-Silva, C. Felipe, 2020, Annals of translational medicine.

Predictive value of urinary retinol binding protein for graft dysfunction after kidney transplantation.

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2003, Transplantation proceedings.

Basiliximab induction in patients receiving tacrolimus-based immunosuppressive regimens

M. Franco, H. Tedesco-Silva, C. Felipe, 2013, International Urology and Nephrology.

Immunotherapy for De Novo Renal Transplantation

C. Felipe, J. Pestana, H. Silva, 2012, Drugs.

Targeting JAK/STAT Signaling to Prevent Rejection After Kidney Transplantation: A Reappraisal.

C. Felipe, C. Baan, N. Kannegieter, 2016, Transplantation.

Long-term outcomes of elderly kidney transplant recipients.

P. Orlandi, C. Felipe, J. M. Pestana, 2015, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium–Based Treatment in Brazilian Kidney Transplant Recipients

M. Hirata, H. Tedesco-Silva, C. Felipe, 2017, Pharmacotherapy.

Risk factors associated with graft loss and patient survival after kidney transplantation.

H. Tedesco-Silva, C. Felipe, P. Pinheiro-Machado, 2009, Transplantation proceedings.

Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus

C. Felipe, J. Medina-Pestana, L. Viana, 2017, Transplantation.

Clinical features and outcomes of kidney transplant recipients with focal segmental glomerulosclerosis recurrence

H. Tedesco-Silva, C. Felipe, G. Kirsztajn, 2019, Nephrology.

An Overview of the Current Status of Organ Donation and Transplantation in Brazil.

M. Abbud-Filho, C. Felipe, J. M. Pestana, 2015, Transplantation.

Steroid or tacrolimus withdrawal in renal transplant recipients using sirolimus

C. Felipe, J. Medina-Pestana, N. Galante, 2011, International Urology and Nephrology.

Tolerability of mycophenolate sodium in renal transplant recipients

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2018, International Journal of Clinical Pharmacy.

Impact of initial exposure to calcineurin inhibitors on kidney graft function of patients at high risk to develop delayed graft function.

M. Franco, H. Tedesco-Silva, C. Felipe, 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus

H. Tedesco-Silva, C. Felipe, P. Pinheiro-Machado, 2009, Fundamental & clinical pharmacology.

Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation

H. Tedesco-Silva, C. Felipe, J. M. Pestana, 2011 .

Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: A retrospective cohort analysis

C. Felipe, L. Viana, H. Silva, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Infectious complications as the leading cause of death after kidney transplantation: analysis of more than 10,000 transplants from a single center

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2017, Journal of Nephrology.

Plasma proteomics for the assessment of acute renal transplant rejection.

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2016, Life sciences.

Impact of cyclosporine dosing frequency on graft function and survival after the conversion from sandimmun to neoral in stable kidney transplanted patients.

C. Felipe, J. Pestana, H. Silva, 2002, Transplantation proceedings.

The influence of clinical, environmental, and socioeconomic factors on five-year patient survival after kidney transplantation

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2018, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

Risk Factors Associated With Graft Loss and Patient Survival After Kidney Transplant

C. Felipe, Sung I Park, J. Medina-Pestana, 2008 .

Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen.

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2011, Transplantation proceedings.

Pharmacogenomics and Personalized Medicine Dovepress Association of the Ppp3ca C.249g>a Variant with Clinical Outcomes of Tacrolimus-based Therapy in Kidney Transplant Recipients

M. Hirata, H. Tedesco-Silva, C. Felipe, 2022 .

Association of the PPP 3 CA c . 249 G > A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients

M. Hirata, H. Tedesco-Silva, C. Felipe, 2017 .

Limitations of the interpretation and extrapolation of clinical trial data in kidney transplant recipients

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2017, Clinical transplantation.

Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy

H. Tedesco-Silva, C. Felipe, L. Viana, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Efficacy and Safety of Elective Conversion From Sotrastaurin (STN) to Tacrolimus (TAC) or Mycophenolate (MPS) in Stable Kidney Transplant Recipients

M. Franco, H. Tedesco-Silva, C. Felipe, 2016, Therapeutic drug monitoring.

Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2015, Transplantation.

Long-term kidney transplant outcomes in patients receiving oil-based or microemulsion formulations of cyclosporine.

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2004, Transplantation Proceedings.

Alemtuzumab induction in kidney transplant recipients

M. Franco, C. Felipe, Sung I Park, 2007, Nature Clinical Practice Nephrology.

Early hospital readmission after kidney transplantation under a public health care system

C. Felipe, L. Viana, M. Cristelli, 2019, Clinical transplantation.

Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients.

C. Struchiner, H. Tedesco-Silva, C. Felipe, 2011, Pharmacogenomics.

Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients.

H. Tedesco-Silva, C. Felipe, R. Schmouder, 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Concentration‐controlled use of sirolimus associated with reduced exposure of cyclosporine in black recipients of primarily living renal allograft donors: 12‐month results

M. Franco, H. Tedesco-Silva, C. Felipe, 2005, Clinical transplantation.

The current burden of cytomegalovirus infection in kidney transplant recipients receiving no pharmacological prophylaxis.

C. Felipe, L. Viana, J. M. Pestana, 2017, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

A prospective randomized trial investigating the influence of pharmaceutical care on the intraindividual variability of tacrolimus concentrations early after kidney transplant.

H. Tedesco-Silva, C. Felipe, L. Viana, 2016, Therapeutic Drug Monitoring.

CYP3A5 Genotype, but Not CYP3A4*1b, CYP3A4*22, or Hematocrit, Predicts Tacrolimus Dose Requirements in Brazilian Renal Transplant Patients

H. Tedesco-Silva, C. Felipe, J. Medina-Pestana, 2013, Clinical pharmacology and therapeutics.

Mycophenolic acid metabolite profile in renal transplant patients receiving enteric-coated mycophenolate sodium or mycophenolate mofetil.

H. Tedesco-Silva, C. Felipe, R. Schmouder, 2005, Transplantation proceedings.

The Association Between Kidney Donor Profile Index and 1-y Graft Function

H. Tedesco-Silva, C. Felipe, Maria Amélia Aguiar Hazin, 2023, Transplantation direct.

Transition from antigenemia to quantitative nucleic acid amplification testing in cytomegalovirus-seropositive kidney transplant recipients receiving preemptive therapy for cytomegalovirus infection

H. Tedesco-Silva, C. Felipe, L. Viana, 2022, Scientific reports.